Due to the COVID-19 pandemic, the Transcatheter Cardiovascular Therapeutics meeting was held virtually. TCT Connect, which ran from Oct. 14 to 18, offered the latest in cutting-edge science for interventional cardiologists.Healio and Cardiology Today asked experts for their opinions on key presentations. Weighing in were Cardiology Today Editorial Board Member Anita W. Asgar, MD, MSc, FRCPC,
Progress has been made in the creation of a new independent Board of Cardiovascular Medicine under the American Board of Medical Specialties, several cardiology societies…
Susan Weiner, MS, RDN, CDCES, FADCES, talks with Sharon Palmer, MSFS, RDN, about benefits of plant-based eating plans for women’s health Weiner: What does plant-based…
Air pollution accentuates the relationship between poor mental health and premature mortality from heart disease in the United States, researchers reported at ESC Preventive Cardiology…
DENVER —Exercise “pretty much improves everything” from metabolic health to musculoskeletal, cardiovascular, pulmonary, mental, sexual and cognitive health, an expert said.The Physical Activity Guidelines for…
DENVER — More than 1,200 clinicians are coming together to learn more about obesity at the Obesity Medicine Association’s 2024 conference, according to a speaker…
Researchers estimated that nearly 60 million individuals aged 45 to 85 years are at average-risk for colorectal cancer and eligible for screening in the U.S.,…
Risk for incident fracture is higher for children born to mothers with type 2 diabetes or gestational diabetes compare with those whose mothers did not…
In a meta-analysis of studies covering more than 400,000 people, climbing stairs was associated with reduced risk for all-cause mortality and death from heart disease.“If…
Progress has been made in the creation of a new independent Board of Cardiovascular Medicine under the American Board of Medical Specialties, several cardiology societies…
RevOpsis Therapeutics closed its first seed funding round and raised $16.5 million to advance RO-104, its lead candidate for the treatment of neovascular age-related macular…
